| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/20/2001 | EP1108029A1 Kunitz domain polypeptide zkun6 |
| 06/20/2001 | EP1108027A1 Hypertension associated transcription factor-1 (hatf-1) and and hatf related protein 1 (hrp-1) |
| 06/20/2001 | EP1108026A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 06/20/2001 | EP1108025A2 Phelix: a testis-specific protein expressed in cancer |
| 06/20/2001 | EP1108024A1 Lim domain protein homolog |
| 06/20/2001 | EP1108023A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 06/20/2001 | EP1108022A1 Cell specific promoters of uncoupling protein 3 |
| 06/20/2001 | EP1108021A2 Human genes differentially expressed in colorectal cancer |
| 06/20/2001 | EP1108020A1 Glycine transporter |
| 06/20/2001 | EP1108019A2 Protein transport-associated molecules |
| 06/20/2001 | EP1108018A1 Human deltex-like gene zdx |
| 06/20/2001 | EP1108015A1 Streptavidin mutants having secondary functional domains |
| 06/20/2001 | EP1108014A1 $i(EHRLICHIA CANIS) 120-KDA IMMUNODOMINANT ANTIGENIC PROTEIN AND GENE |
| 06/20/2001 | EP1108013A2 Genes associated with neurotransmitter processing |
| 06/20/2001 | EP1108009A1 Compositions and methods for producing high-level seed-specific gene expression in corn |
| 06/20/2001 | EP1107992A2 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6 |
| 06/20/2001 | EP1107991A1 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120 |
| 06/20/2001 | EP1107989A2 Expression and export of angiostatin and endostatin as immunofusins |
| 06/20/2001 | EP1107988A2 Method for chromatographically purifying insulins |
| 06/20/2001 | EP1107987A2 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor |
| 06/20/2001 | EP1107986A1 Protein domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 and methods of making and using the same |
| 06/20/2001 | EP1107985A1 Basic peptides and pharmaceutical compositions containing same |
| 06/20/2001 | EP1107984A1 Modified synthetic dna sequences for improved insecticidal control |
| 06/20/2001 | EP1107983A2 Benzodiazepine and benzothiazepine derivatives and hbsag peptides binding to annexins, their compositions and use |
| 06/20/2001 | EP1107980A1 CRYSTALLINE FORMS OF EtO 2?C-CH 2?-($i(R))Cgl-Aze-Pab-OH |
| 06/20/2001 | EP1107979A2 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 06/20/2001 | EP1107978A1 Secreted proteins and polynucleotides encoding them |
| 06/20/2001 | EP1107977A1 Ratc |
| 06/20/2001 | EP1107976A1 Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor |
| 06/20/2001 | EP1107798A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 06/20/2001 | EP1107797A2 Hypoxia regulated genes |
| 06/20/2001 | EP1107796A2 Cells expressing immunoregulatory molecules and uses therefor |
| 06/20/2001 | EP1107794A2 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 06/20/2001 | EP1107793A1 Dextran-leptin conjugates, pharmaceutical compositions and related methods |
| 06/20/2001 | EP1107789A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/20/2001 | EP1107788A1 Scrp-5: secreted cysteine rich protein-5 |
| 06/20/2001 | EP1107787A2 Salmonella typhi vaccine compositions |
| 06/20/2001 | EP1107786A2 Recombinant subunit vaccine against flaviviral infection |
| 06/20/2001 | EP1107774A1 Ramp2a: receptor activity modifying protein-2a |
| 06/20/2001 | EP1107768A1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE |
| 06/20/2001 | EP1035780A4 Method for purifying heat shock peptides complexes |
| 06/20/2001 | EP0889902B1 Antibiotic peptides from bovine milk |
| 06/20/2001 | EP0842188A4 Mutant s182 genes |
| 06/20/2001 | EP0754194B1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 06/20/2001 | EP0662157B1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 06/20/2001 | EP0652954B1 A novel gene vector coding human epidermal growth factor and process for preparing the same |
| 06/20/2001 | CN1300367A Methods and compositions for diagnosis of rheumatoid arthritis |
| 06/20/2001 | CN1300324A Glyphosate as a gametocide |
| 06/20/2001 | CN1300320A Assay for the diagnosis of schizophrenia based on a new peptide |
| 06/20/2001 | CN1300295A Hybrid protein for inhibiting the deatanulation of mastocytes and the use thereof |
| 06/20/2001 | CN1300294A Frameshift mutants of beta-amyloid precursor protein and ubiquitin-B and their use |
| 06/20/2001 | CN1300222A Strategically modified hepatitis b core proteins and their derivatives |
| 06/20/2001 | CN1300220A Peptide compositions and formulations and use of same |
| 06/20/2001 | CN1299973A HCV-free-blood external preparing method |
| 06/20/2001 | CN1299873A Gene synthesis, expression plasmid construction and product production of human 16 interferon |
| 06/20/2001 | CN1299872A Gene synthesis, expression plasmid construction and product production of human alpha 26 interferon |
| 06/20/2001 | CN1299870A Lycoris agglutinin protein and its code sequence |
| 06/20/2001 | CN1299832A New human cell cycle regulating protein and its code sequence and use |
| 06/20/2001 | CN1299831A New interferon-like protein and its code sequence and use |
| 06/20/2001 | CN1299830A New human heat shock protein and its code sequence and use |
| 06/20/2001 | CN1299829A New human cell cycle regulating protein and its code sequence and use |
| 06/20/2001 | CN1299828A New cell factor acceptor and its code sequence and use |
| 06/20/2001 | CN1299827A New human CD20 homolgous molecule and its code sequence and use |
| 06/20/2001 | CN1299826A Colored mistletoe herb glycoprotein extraction and its medicine composite and preparation |
| 06/20/2001 | CN1299825A New human zinc finger transcription factor and its code sequence |
| 06/20/2001 | CN1299824A New human coupling acceptor and its code sequence |
| 06/20/2001 | CN1299823A New human cell factor and its code sequence and use |
| 06/20/2001 | CN1299822A New complex process of preparing recombined isomer of tissue-type plasminogen activator |
| 06/20/2001 | CN1067460C Pumping device |
| 06/20/2001 | CN1067431C Process for construction and purifying of recombinant human lymph toxin alpha deriv a |
| 06/20/2001 | CN1067403C Direct high-purity peptide-inhibiting enzyme extraction method from ox lungs |
| 06/19/2001 | US6248937 Transcription factor and method for regulation of seed development, quality and stress-tolerance |
| 06/19/2001 | US6248935 Nucleotide sequences coding regulatory protein associated with pollen formation; for use in controlled gene expression in plant anthers |
| 06/19/2001 | US6248875 Nucleotide sequence coding brain protein; for use in diagnosis of central nervous system defects |
| 06/19/2001 | US6248873 Nucleotide sequences associated with cardiovascular disorders; for the detection of genetic adjustment in the genome |
| 06/19/2001 | US6248869 Troponin I forms and use of the same |
| 06/19/2001 | US6248868 Phragmoplastin and methods of examining cell plate development |
| 06/19/2001 | US6248867 Polypeptide associated with proper eye function; for the diagnosis of vision defects |
| 06/19/2001 | US6248864 Compounds and methods and modulating tissue permeability |
| 06/19/2001 | US6248863 Phoh homolog |
| 06/19/2001 | US6248723 Method for treatment of inflammatory disease |
| 06/19/2001 | US6248721 Method of using mouse model for evaluation of HIV vaccines |
| 06/19/2001 | US6248716 Prophylaxis or treatment of physical or mental stress-related disorders in an animal by administering an effective oligopeptide including tyrosine and phenylalanine units |
| 06/19/2001 | US6248714 Methods of inhibiting binding and treating Ig-mediated responses with IL-13 receptor |
| 06/19/2001 | US6248713 Cell adhesion inhibitors |
| 06/19/2001 | US6248712 Urokinase-type plasminogen activator receptor |
| 06/19/2001 | US6248594 Kinesin-like motor protein |
| 06/19/2001 | US6248584 Nucleic acid encoding a p100 transcription coactivator of defined amino acid sequence or the complement of the nucleic acid; for altered levels of activator in transformed host cells such as plants and seeds |
| 06/19/2001 | US6248583 Chromosomally-encoded membrane protein of borrelia burgdorferi |
| 06/19/2001 | US6248582 Gene deleted recombinant FeLV proviral DNA for production of vaccines against FeLV |
| 06/19/2001 | US6248581 Mycobacteria functional screening and/or expression vectors |
| 06/19/2001 | US6248578 Infectious clone for human parainfluenza virus type 3 |
| 06/19/2001 | US6248576 Histidinol dehydrogenase |
| 06/19/2001 | US6248574 Fusion protein of polypeptide derived from gp41 or gp120 of defined amino acid sequence and a non-human immunodeficiency virus polypeptide sequence; diagnosis; immunotherapy; immunotoxins; vaccines |
| 06/19/2001 | US6248564 Mutant MHC class I molecules |
| 06/19/2001 | US6248563 Chlamydia trachomatis serotype D genes |
| 06/19/2001 | US6248562 Chimeric proteins comprising borrelia polypeptides and uses therefor |
| 06/19/2001 | US6248561 UCP3 genes |
| 06/19/2001 | US6248560 Nucleic acid encoding the analog which has at least one cysteine substituted with another amino acid to enhance formation of heterodimers; enhanced biological activity; treatment of gastrointestinal and hematopoietic disorders |
| 06/19/2001 | US6248557 RatC |